Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 13, 2025, Thomas Bures was appointed to serve as the Chief Accounting Officer of Bruker Corporation (the "Company"), effective immediately.

In connection with his appointment as Chief Accounting Officer, Mr. Bures and the Company entered into an Offer Letter (the "Offer Letter") providing for an annual base salary of $415,000.04 and eligibility for an incentive bonus of 45% of base salary. In addition, Mr. Bures is entitled to receive, effective on or about February 15, 2025, a grant of 2,972 Restricted Stock Units ("RSUs") under the Company's 2016 Incentive Compensation Plan which will vest ratably 25% per year over four years, beginning on the first anniversary of the grant date (the "RSU Grant"). The RSU Grant will be made pursuant to the Company's Form of Restricted Stock Unit Agreement, as filed as Exhibit 10.8 to the Company's Form 10-K for the year ended December 31, 2023.

Mr. Bures, age 50, has more than 20 years of finance experience and has spent the last several years managing finance organizations within the healthcare and life sciences industry. Mr. Bures was most recently the Senior Vice President and Chief Financial Officer of Pieris Pharmaceuticals (formerly listed on Nasdaq: PIRS) from October 2021 to December 2024 and before that, he served in the role of Vice President, Finance since December 2017. Prior to that position, he served as the Vice President and Corporate Controller of Genocea Biosciences Inc. (formerly listed on Nasdaq: GNCA) since 2015 and was responsible for the financial reporting, accounting, tax, treasury and insurance functions. Before joining Genocea, Mr. Bures worked for five years at PAREXEL International Corporation (formerly listed on Nasdaq: PRXL), most recently as the Vice President and Assistant Controller. He was responsible for financial reporting, internal controls, and GAAP and statutory accounting for all legal entities. He started his career in Ernst and Young's audit practice in 1996 and served multinational clients in the retail, manufacturing and banking industries. Mr. Bures received his B.A. in Accounting and Finance from the College of the Holy Cross.

There are no other arrangements or understandings between Mr. Bures and any other persons pursuant to which he was selected as the Company's Chief Accounting Officer. Mr. Bures does not have any family relationship with any executive officer or director of the Company, or with any person selected to become an officer or director of the Company. Neither Mr. Bures nor any member of his immediate family has any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.